Lead the development of the drug substance and drug product at outsourced CMOs, from development to commercialization.Design and optimize formulations to support product development, preclinical and clinical studies.Plan activities and timelines to ensure proper integration and alignment with the overall project plan.Develop formulations with different rout of administration (from oral to SC and transdermal). Preparation of CMC documents for submission and writing development reports.

Developing drug products based on oral Insulin technology to treat rare diseases of the gastrointestinal tract and impact short- and long-term morbidities of pre-term infants, children, and adults.

Engages in the development of generic products in accordance with applicable regulation, quality characteristics of the drug product and project management methodologies:- Development of Extended release, Delay release and Immediate release drugs for oral dosage form such as capsules, tablets, minitablets and pellets- Multidisciplinary coordination of the projects with RA, QA, Analytical and Operation team groups- Selecting the type and amount of excipients to deliver drug product of desired quality- Writing CMC documents for submissions (module 3)- Preforming scale up process activities and production of clinical batches in different Teva sites - Submission of successful drug products to EU and US authorities

Teaching laboratory courses for basic and advanced methods in Molecular biology, Microbiology, Organic chemistry, and Biochemistry

Development of drug products utilizing a proprietary active transdermal drug delivery technology

Quality Assurance tester. Involved in testing of printed circuits.